Home > Boards > US OTC > Miscellaneous > Reliability Inc. (RLBY)

When these people own over 90% of the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Walker Member Profile
Member Level 
Followed By 592
Posts 68,272
Boards Moderated 6
Alias Born 08/09/00
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2019 5:20:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2019 5:20:23 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/31/2019 1:11:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/30/2019 6:18:03 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/29/2019 7:32:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/29/2019 7:32:20 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/29/2019 7:29:52 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/29/2019 7:28:02 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/29/2019 7:26:51 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/29/2019 7:26:36 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/29/2019 7:24:05 PM
Amended Statement Regarding Change in Majority of Directors Pursuant to Rule 14f-1 (sc 14f1/a) Edgar (US Regulatory) - 10/10/2019 6:02:11 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/23/2019 7:29:04 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2019 4:15:50 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 3:13:00 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 3/29/2019 1:31:37 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/28/2019 4:51:20 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2018 5:04:12 PM
Walker Member Level  Thursday, 10/10/19 07:32:35 AM
Re: doebop post# 1647
Post # of 3626 
When these people own over 90% of the O/S you are in pretty good hands:

New Directors - About as impressive as it gets -

Mark Speck, Chief Financial Officer, Director

Mr. Speck is an executive who leverages technology, business intelligence, innovation, enterprise-wide synergies, M&A opportunities, team development, and smart risk to capture opportunities for aggressive growth.

Mr. Speck has 25+ years of business experience and has held executive and senior leadership roles in the areas of finance, audit, business development, operations, and compliance across a range of technology, software, legal and professional service, staffing, telecommunications, consulting, non-profit, and government contracting industries for a variety of public, private, and private equity held firms.

Mr. Speck has served as the Chief Financial Officer for Maslow since April 2019. Prior to this, Mr. Speck was the COO and CFO of a Specktrum, Inc. a finance, accounting and compliance services firm he founded, titled In that capacity he raised capital, led sales, marketing, operations, and finance. He served in this capacity from August 2017 to March 31, 2019 prior to joining Maslow.

Previously, Mr. Speck was CFO of CPA Global North America, an intellectual property lifecycle management firm with US headquarters in Alexandria, Virginia, from February 2010 to June 2011, and Chief Compliance Officer and Head of Internal Audit of CPA Global corporate based out of St. Hellier, Jersey, Channel Islands from June 2011 to August 2017. As CFO he presided over financial management of 50% of the firm’s $3.1B customer portfolio facilitating double digit growth by establishing fiscal discipline in terms of internal controls and policies, installing improved cash conversion facilities, implementing KPI’s for 5 separate lines of business, including its sales pipeline, and upgrading the region’s financial reporting requirements which were later employed as group global reporting standards. Mr. Speck also introduced a revenue enhancement program that generated a multi-million annuitized impact.

In 2011, Mr. Speck was asked to set up and lead CPA Global’s a regulatory compliance programme, which was required to complete a capital event, so he was named the firm’s global Chief Compliance Officer and Head of Internal Audit, a post he presided over for 6 years. In this capacity he was responsible for global compliance covering regulations in 14 countries on 5 continents. As head of internal audit his team added value by driving organizational and operating optimization and detecting revenue and cost savings opportunities that often had a financial impact which often exceeded his organizational budget. He also led the formal creation of both a data protection and anti-bribery and corruption programs.

Nick Tsahalis, President

Nick Tsahalis currently serves as the Chief Executive Officer of Maslow, and has served in such capacity since July 2017. Mr. Tsahalis joined Maslow in 2015 as its Chief Financial Officer. Prior to joining Maslow, he previously served as Chief Financial Officer of Recycled Green Industries, a company that processed food scraps into composted materials with commercial applications from June 2011 to July 2015. Prior to that, he served as Chief Financial Officer of Atlantic Video Productions & Internet Services, Inc., which provided production and internet services. In each position as CFO, he was responsible for managing the company's finances, including financial planning, management of financial risks, record-keeping, and financial reporting. He received his degree in Accounting from the University of Maryland, Robert H. Smith School of Business.

Naveen Doki, Director

Naveen Doki is a clinically trained Hematologist and Oncologist. He obtained his MD from India and trained in Internal Medicine at UC Irvine and completed his fellowship in Hematology and Oncology at University of Sothern California. Shortly after completing his fellowship, Dr. Doki started his own practice in Fairfax, VA after a 3 month stint at a local practice in Frederick, MD.

Mr. Doki is an entrepreneur who has invested in real-estate, information technology, infrastructure and urgent care practices. He previously owned an urgent care facility, CareMed, LLC in Virginia which he divested in early 2019. In May of 2012, he acquired an existing practice called Hematology Oncology Care of Northern Virginia. in Fairfax, Virginia, where he practices as a Hematologist-Oncologist. Since Sep, 2019, he has held a majority ownership interest in a technology services company, Futuris Technology Services, Inc. located in Virginia.

He has active medical licenses in Virginia, California and Maryland. He is board certified by ABIM in Medical Oncology. Prior to relocating to the United States, he worked for Kingston Public Hospital in Jamaica.

He is the husband of Dr. Shirisha Janumpally, who is also to become a director of the Company.

Dr. Silvija Valleru, Director

Silvija Valleru has been practicing dentistry for over 20 years. She earned her Doctor of Dental Surgery (DDS) in 1998 from the University of the Pacific. From 1999-Present Dr. Valleru has been a resident dentist at the Dental Care Alliance in Woodbridge, VA. She previously practiced dentistry and co-managed her dental practice in Loudoun County, VA between 2009 and 2013. She owned her own facility with her partner in Loudoun County and divested it out in early 2016.


Dr. Valleru has made several private investments in real-estate and information technology. She made investments in Maslow Media Group, Futuris Technology Services, Inc and an office building in Rockville, MD.

Dr. Shirisha Janumpally, Director

Shirisha Janumpally, MD is a board-certified neurologist and sleep specialist that has been practicing for 18 years. She is also a member of the American Academy of Sleep Medicine, American Academy of Neurology and American Medical Association. She has worked in both academic and community settings as a neurologist and sleep medicine specialist.

Ms. Janumpally completed her internship at Loma Linda University Medical center in Internal medicine.

Subsequently, she completed her neurology residency and sleep medicine training at University of California-Irvine (UCI) Medical Center. During her residency her research focus was on the role of dopamine agonists (which are used to treat restless leg syndrome) in causing impulse control behavior disorders. Following her training she worked as a sleep medicine attending physician as well as an Assistant Professor of Neurology at UCI Medical Center. Her clinical interests include sleep related breathing disorders, parasomnias, and circadian rhythm disorders.

From 2014 to present, Ms. Janumpally has been an active practicing neurologist within SJanumpally, Inc.

She is an active investor in various businesses and currently has holdings in real-estate and information technology within IQS, Corp in Minneapolis, MN and Senryo, Inc. in Chicago, Illinois.

Jeff Eberwein: LinkedIn Experience Summary

CEO and Board Member
Hudson Global, Inc.
Apr 2018 – Present1 year 7 months

Founder and CEO
Lone Star Value Management, LLC
Jan 2012 – Present7 years 10 months

Chairman of the Board
Apr 2012 – Present7 years 7 months

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist